Commercial Information Circulars

24-hour hotline : 23 922 922

e-mail address : enquiry@tid.gov.hk

Ref. : EIC 631/2/5

28 February 2017

Dear Sirs,

Commercial Information Circular No. 172/2017

The Mainland of China : Public Consultation on "Notice Concerning Matters Relating to the Re-registration of Drugs (Consultation Draft)"

The China Food and Drug Administration (CFDA) of the People's Republic of China is seeking comments from the public on the "Notice Concerning Matters Relating to the Re-registration of Drugs (Consultation Draft)". Interested parties can submit their comments to CFDA by email before 13 April 2017. Please refer to the Appendix (pdf format) for the notice (available in Chinese only).

ENQUIRIES

2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.

Yours faithfully,

(Ms Helen CHENG)
for Director-General of Trade and Industry

Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.